{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:01:27Z","timestamp":1790726487673,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["Z221100007422067"],"award-info":[{"award-number":["Z221100007422067"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["L232082"],"award-info":[{"award-number":["L232082"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270133"],"award-info":[{"award-number":["82270133"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82570178"],"award-info":[{"award-number":["82570178"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.rpth.2026.103425","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T19:09:49Z","timestamp":1774465789000},"page":"103425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Emicizumab prophylaxis vs immune tolerance induction in children with severe hemophilia A and inhibitors: a retrospective comparison of bleeding control, quality of life, and cost"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6290-9074","authenticated-orcid":false,"given":"Zhengping","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzi","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanru","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5273-145X","authenticated-orcid":false,"given":"Zhenping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4030-209X","authenticated-orcid":false,"given":"Runhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.103425_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28474","article-title":"Outcomes in children with hemophilia A with inhibitors: results from a noninterventional study","volume":"67","author":"Oldenburg","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.rpth.2026.103425_bib2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ajh.23957","article-title":"Impact of inhibitors on hemophilia A mortality in the United States","volume":"90","author":"Walsh","year":"2015","journal-title":"Am J Hematol"},{"issue":"Suppl 4","key":"10.1016\/j.rpth.2026.103425_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/hae.14553","article-title":"Inhibitors: diagnostic challenges, unknowns of inhibitor development, treatment of bleeding and surgery, and insights into diagnosis and treatment in China","volume":"28","author":"Escuriola Ettingshausen","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103425_bib4","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/hae.14880","article-title":"Efficacy, safety and cost of emicizumab prophylaxis in haemophilia A patients with inhibitors: a nationwide observational study in Taiwan","volume":"29","author":"Shen","year":"2023","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103425_bib5","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1182\/blood-2011-08-369132","article-title":"The principal results of the International Immune Tolerance Study: a randomized dose comparison","volume":"119","author":"Hay","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.103425_bib6","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1182\/blood.2020009217","article-title":"Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies","volume":"137","author":"Callaghan","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.103425_bib7","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/hae.13819","article-title":"Immune tolerance induction in paediatric patients with haemophilia A and inhibitors receiving emicizumab prophylaxis","volume":"25","author":"Batsuli","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103425_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102639","article-title":"Intermediate-dose immune tolerance induction outperforms with faster success, less bleeding, and no added cost in comparison with low dose: a multicenter randomized clinical trial","volume":"9","author":"Li","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103425_bib9","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1111\/hae.14635","article-title":"Individualised prophylaxis based on personalised target trough FVIII level optimised clinical outcomes in paediatric patients with severe haemophilia A","volume":"28","author":"Huang","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103425_bib10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1477-7525-10-112","article-title":"Cross-cultural adaptation of the CHO-KLAT for boys with hemophilia in rural and urban China","volume":"10","author":"Wu","year":"2012","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.rpth.2026.103425_bib11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1365-2516.2012.02909.x","article-title":"Guidelines for the management of hemophilia","volume":"19","author":"Srivastava","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103425_bib12","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/hae.15062","article-title":"Reduced doses of emicizumab achieve good efficacy: Results from a national-wide multicentre real-world study in China","volume":"30","author":"Xu","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103425_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/hae.14456","article-title":"Low-dose immune tolerance induction therapy in children of Arab descent with severe haemophilia A, high inhibitor titres and poor prognostic factors for immune tolerance induction treatment success","volume":"28","author":"Elalfy","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103425_bib14","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/hae.14381","article-title":"Immune tolerance induction in severe haemophilia A: a UKHCDO inhibitor and paediatric working party consensus update","volume":"27","author":"Hart","year":"2021","journal-title":"Haemophilia"},{"issue":"Suppl 1","key":"10.1016\/j.rpth.2026.103425_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2516.2007.01497.x","article-title":"International workshop on immune tolerance induction: consensus recommendations","volume":"13","author":"DiMichele","year":"2007","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.rpth.2026.103425_bib16","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.transci.2019.08.008","article-title":"Hemophilia A with inhibitor: Immune tolerance induction (ITI) in the mirror of time","volume":"58","author":"Nakar","year":"2019","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.rpth.2026.103425_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12562","article-title":"Low-dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia A inhibitors","volume":"5","author":"Li","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.103425_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2024.109110","article-title":"A long term outcomes analysis of severe haemophilia A boys receiving 4 years prophylaxis on the Chinese Haemophilia Individualized escalating low dose Prophylaxis (CHIPS)","volume":"241","author":"Yao","year":"2024","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.103425_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.yapd.2022.03.009","article-title":"Advances in hemophilia A management","volume":"69","author":"Cho","year":"2022","journal-title":"Adv Pediatr"},{"issue":"Suppl 3","key":"10.1016\/j.rpth.2026.103425_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/hae.14982","article-title":"Haemophilia in the era of novel therapies: where do inhibitors feature in the new landscape?","volume":"30","author":"Meeks","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103425_bib21","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1182\/blood.2019001869","article-title":"A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors","volume":"134","author":"Young","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.103425_bib22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/hae.15134","article-title":"Pain-related quality of life outcomes in people with haemophilia A receiving emicizumab: a post hoc analysis of the HAVEN 1, 3 and 4 and STASEY studies","volume":"31","author":"Hermans","year":"2025","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.103425_bib23","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1055\/s-0043-1777766","article-title":"Surgical experience from the STASEY study of emicizumab prophylaxis in people with hemophilia A with factor VIII inhibitors","volume":"8","author":"Castaman","year":"2024","journal-title":"TH Open"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247503792600083X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247503792600083X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:16:24Z","timestamp":1790723784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S247503792600083X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S247503792600083X"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.103425","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emicizumab prophylaxis vs immune tolerance induction in children with severe hemophilia A and inhibitors: a retrospective comparison of bleeding control, quality of life, and cost","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.103425","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"103425"}}